Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is Hyperglycemia  [Clear All Filters]
2020
Tang O, Matsushita K, Coresh JJ, et al. "Mortality Implications of Prediabetes and Diabetes in Older Adults." Diabetes Care. 2020;43(2):382-388.
2019
Rawlings AM, Sharrett ARichey, Albert MS, et al. "The Association of Late-Life Diabetes Status and Hyperglycemia With Incident Mild Cognitive Impairment and Dementia: The ARIC Study." Diabetes Care. 2019;42(7):1248-1254.
Loomis SJ, Tin A, Coresh JJ, et al. "Heritability analysis of nontraditional glycemic biomarkers in the Atherosclerosis Risk in Communities Study." Genet Epidemiol. 2019;43(7):776-785.
Marrone MT, Selvin E, Barber JR, Platz EA. "Hyperglycemia, Classified with Multiple Biomarkers Simultaneously in Men without Diabetes, and Risk of Fatal Prostate Cancer." Cancer Prev Res (Phila). 2019;12(2):103-112.
2017
Godino JG, Appel LJ, Gross AL, et al. "Diabetes, hyperglycemia, and the burden of functional disability among older adults in a community-based study." J Diabetes. 2017;9(1):76-84.
Li M, Maruthur NM, Loomis SJ, et al. "Genome-wide association study of 1,5-anhydroglucitol identifies novel genetic loci linked to glucose metabolism." Sci Rep. 2017;7(1):2812.
Warren B, Rawlings AM, Lee AK, Grams M, Coresh JJ. "Increases in Biomarkers of Hyperglycemia With Age in the Atherosclerosis Risk in Communities (ARIC) Study." Diabetes Care. 2017;40(8):e96-e97.
Rebholz CM, Grams ME, Chen Y, Gross AL, Sang Y, Coresh JJ. "Serum Levels of 1,5-Anhydroglucitol and Risk of Incident End-Stage Renal Disease." Am J Epidemiol. 2017;186(8):952-960.
2016
"Are There Clinical Implications of Racial Differences in HbA1c? A Difference, to Be a Difference, Must Make a Difference." Diabetes Care. 2016;39(8):1462-7.
Parrinello CM, Sharrett ARichey, Maruthur NM, Bergenstal RM, Grams ME, Coresh JJ. "Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia." Diabetes Care. 2016;39(4):589-95.
2014
Selvin E, Rawlings AM, Grams M, Klein R, Steffes M. "Association of 1,5-anhydroglucitol with diabetes and microvascular conditions." Clin Chem. 2014;60(11):1409-18.
2013
Bell EJ, Selvin E, Lutsey PL, Nambi V, Cushman M. "Glycemia (hemoglobin A1c) and incident venous thromboembolism in the Atherosclerosis Risk in Communities cohort study." Vasc Med. 2013;18(5):245-50.
2012
Juraschek SP, Steffes MW, Miller ER. "Alternative markers of hyperglycemia and risk of diabetes." Diabetes Care. 2012;35(11):2265-70.
Rubin J, Matsushita K, Ballantyne CM, Hoogeveen RC, Coresh JJ. "Chronic hyperglycemia and subclinical myocardial injury." J Am Coll Cardiol. 2012;59(5):484-9.
Rubin J, Nambi V, Chambless LE, et al. "Hyperglycemia and arterial stiffness: the Atherosclerosis Risk in the Communities study." Atherosclerosis. 2012;225(1):246-51.
Liu C-T, C Y Ng M, Rybin D, et al. "Transferability and fine-mapping of glucose and insulin quantitative trait loci across populations: CARe, the Candidate Gene Association Resource." Diabetologia. 2012;55(11):2970-84.
2007
Wong TY, Klein R, Amirul Islam FM, et al. "Three-year incidence and cumulative prevalence of retinopathy: the atherosclerosis risk in communities study." Am J Ophthalmol. 2007;143(6):970-6.
2005
Selvin E, Coresh J, Shahar E, Zhang L, Steffes M, A Sharrett R. "Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study." Lancet Neurol. 2005;4(12):821-6.
2003
Schmidt M I, Duncan BB, Vigo A, et al. "Detection of undiagnosed diabetes and other hyperglycemia states: the Atherosclerosis Risk in Communities Study." Diabetes Care. 2003;26(5):1338-43.